Using our mobile app? Be sure to check for any new app updates to receive any enhancements.
Logo

Get Healthy!

Results for search "Arthritis: Drugs".

Health News Results - 25

Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation.

The options might seem overwhelming, though. Here, the Arthritis Foundation offers some suggestions for meds that can be purchased at a local drug store or filled with a doctor's prescription, whether your pain is caused by normal wear and tear (osteoarthritis) or inflamma...

An anti-inflammatory drug that has been around for over 2,000 years might help delay a very modern problem: hip and knee replacements.

That's the suggestion of a new study finding that older adults who used the drug — called colchicine — were less likely to need hip or knee replacement surgery over the next two years, versus those given placebo pills.

The study, published May 30...

Man's aging best friend has a new treatment to dull osteoarthritis pain as the U.S. Food and Drug Administration (FDA) announced approval Friday of the first monoclonal antibody for dogs.

Called Librela, the bedinvetmab shot controls pain from the most common form of arthritis in dogs. Osteoarthritis (OA) affects about 25% of dogs during their lifetime.

In this condition, the cartil...

There are more than 100 types of arthritis and related conditions, and they affect at least 54 million adults and 300,000 children in the United States, according to the Arthritis Foundation.

Fortunately, there are also many medications, non-medication optio...

Arthritis is a common disease that causes pain and inflammation in different body joints, making it difficult to enjoy everyday tasks and physical activity.

Fortunately, there are many different medications for arthritis. Depending on what type of arthritis you have and its severity, an arthritis medication may help you manage pain and other symptoms. Here is a breakdown of the most comm...

Corticosteroid injections to relieve pain in patients with knee osteoarthritis could actually be setting them back.

Two new studies have discovered that, despite the temporary relief of symptoms, the injections were associated with continued progression of the disease.

On the other hand, patients injected with another symptom reliever, hyaluronic acid, saw decreased progression of t...

Over-the-counter pain relievers like aspirin, Aleve or ibuprofen don't do a thing to slow the progression of knee arthritis, and might even make things worse, a new study suggests.

Knee arthritis patients who regularly took nonsteroidal anti-inflammatory drugs (NSAIDs) wound up with worse knee inflammation and weakened cartilage, compared to a "control" group not taking the medications, <...

Long-term steroid use can reshape the structure of the brain, causing some parts to shrink and others to grow, a major new study reports.

People taking steroids -- even inhaled steroids -- appear to have less intact white matter structure in their brains compared with those not taking the drugs, brain scans reveal. White matter serves as the communication link between different regions of...

Physical therapy for knee arthritis tends to cost patients more out-of-pocket and involves a lot more hassle than a quick steroid shot to soothe an aching joint.

But in the long run, physical therapy is at least as cost-effective as steroid injections and is more likely to provide longer-term relief, a new study concludes.

"Even though maybe the initial costs of physical therapy are...

Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson's disease, new research shows.

Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson's, and it was suggested that a class of rheumatoid arthritis drugs called disease-modifying antirheumatic drugs (DMARDs) may play a role in that reduced risk.

To learn mor...

Allopurinol, a frequently used gout medication, does not appear to drive up the risk for dying among gout patients who also struggle with chronic kidney disease, new research shows.

The finding is based on an analysis of two decades worth of British health records. And it may put to rest recent concerns regarding a well-known drug that both gout patients and kidney disease patients have u...

"Ultra-low" doses of the drug rituximab may be enough to keep some patients' rheumatoid arthritis under control for several years, a new, preliminary study suggests.

Researchers found that among 118 patients, low doses of the drug were comparable to standard ones in controlling flare-ups for up to four years.

The findings, the researchers said, suggest that some patients can try low...

As doctors around the world come up against severe cases of COVID-19, some positive news has emerged: New research shows the rheumatoid arthritis drug baricitinib may help reduce hospitalized COVID patients' risk of death.

Current standard-of-care medications aren't enough, said study co-author Dr. E. Wesley Ely, a professor of medicine at Vanderbilt University Medical Center in Nashville...

Commonly used beta blocker heart medicine may also reduce the risk of knee and hip osteoarthritis and pain, a new study suggests.

"Osteoarthritis is the most common form of arthritis and affects 15% of the general population," said study co-authors Georgina Nakafero and Abhishek Abhishek, from the University of Nottingham in England.

In a joint statement to Healio Rheumatology

Two new studies suggest that the jury is still out on whether the arthritis drug tocilizumab helps those with severe COVID-19.

Both reports were published recently in the New England Journal of Medicine. The first, from scientists at the University of California, San Diego, found tocilizumab didn't improve outcomes or reduce the risk of death in patients with severe COVID-19 pneu...

Rheumatoid arthritis drugs may save lives of patients hospitalized with severe cases of COVID-19, according to a groundbreaking clinical trial.

The findings, first announced in January, have now been peer-reviewed and published in a major medical journal.

"We are delighted that our full results are now published after peer review. This confirms the robustness of our findings, that t...

The arthritis drug tocilizumab doesn't help hospital patients with severe COVID-19, according to a new study that contradicts earlier research suggesting that it might aid recovery.

In fact, patients receiving tocilizumab had a higher risk of death, so the trial was halted early.

Tocilizumab blocks a part of the immune system (interleukin 6) that can become overactive in some COVID...

About 30 million U.S. adults live with osteoarthritis and the pain and stiffness it causes, a new survey finds.

And nearly one-third of these people said their symptoms are not well-managed, according to the Arthritis Foundation survey of almost 2,000 adults. In osteoarthritis, the cartilage cushioning the joints gradually wears down, leading to swelling, and limiting a person's abili...

A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports.

Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treated with a standard disease-modifying antirheumatic drug (DMARD), said co-resea...

Lots of people are using medical marijuana to treat their arthritis and other muscle aches and pains, often without consulting their doctor, a new study reports.

As many as 1 in 5 patients who consult an orthopedic surgeon for chronic musculoskeletal pain are using a cannabis product to treat them, Canadian researchers found.

"We found 20% had reported past or current use of...

In the scramble to find medicines that beat back COVID-19, researchers from Italy report encouraging results from a small study on a rheumatoid arthritis drug already in use.

The drug, anakinra, may help quiet the runaway immune response known as a "cytokine storm," which imperils some patients with severe COVID-19.

"Until a vaccine is available, we urgently need to find a w...

Medications called SGLT2 inhibitors lower blood sugar in people with type 2 diabetes. And new research suggests these drugs may have an added benefit -- lowering the risk of gout.

Compared with people taking another class of diabetes drugs (GLP1 receptor agonists), those taking the SGLT2 drugs had 36% reduced odds of developing gout, the painful condition that usually starts in t...

A new drug might be able to save a person's knees from the ravages of osteoarthritis, researchers report.

People taking the drug, code named MIV-711, had less bone and cartilage loss than others given a placebo.

"We know that bone slowly changes shape as knee osteoarthritis progresses," said lead researcher Philip Conaghan, a professor at the Leeds Institute of Rheumatic an...

More Americans use marijuana to help them cope with an illness than just to get high, a new study finds.

Nearly 46% of those who use pot say they do so because of a medical condition, compared with 22% who say they use marijuana for recreation.

And only 36% of those with a medical problem say they use pot to get high, compared with 58% of other users, resear...

TUESDAY, May 14, 2019 (HealthDay News) -- Glucosamine has long been used as a supplement to help ease the joint pain of arthritis, but new research suggests its anti-inflammatory properties might also lower heart disease risk.

The finding stems from a lifestyle survey involving more than 466,000 British men and women. None had been diagnosed with heart disease when they were first po...